We are live on ! Find out more
PSTX

Poseida Therapeutics, Inc. Common Stock
PSTX

Delisted

PSTX was delisted on the 7th of January, 2025.

Back to rankings

68 hedge funds and large institutions have $140M invested in Poseida Therapeutics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

257% more call options, than puts

Call options by funds: $200K | Put options by funds: $56K

141% more capital invested

Capital invested by funds: $58.1M → $140M (+$81.6M)

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

100% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 12

82% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 11

21% more funds holding

Funds holding: 56 → 68 (+12)

Holders
68
Holders Change
+12
Holders Change %
+21.43%
% of All Funds
1.17%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
24
Increased
20
Reduced
11
Closed
12
Calls
$200K
Puts
$56K
Net Calls
+$144K
Net Calls Change
+$139K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$10.4M
2
EC
EcoR1 Capital
California
+$8.76M
3
SCM
Silverarc Capital Management
Massachusetts
+$7.19M
4
PBA
Paradigm Biocapital Advisors
New York
+$6.85M
5
CAM
Cormorant Asset Management
Massachusetts
+$6.12M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$2.85M
2
JP Morgan Chase
JP Morgan Chase
New York
-$400K
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$233K
4
E
Ergoteles
New York
-$140K
5
Renaissance Technologies
Renaissance Technologies
New York
-$122K
Name Holding Trade Value Shares
Change 		Change in
Stake
CSS
51
Cubist Systematic Strategies
Connecticut
$55K +$51.3K +15,510 New
Wells Fargo
52
Wells Fargo
California
$50K +$427 +129 +0.9%
Prudential Financial
53
Prudential Financial
New Jersey
$44K +$41.7K +12,600 New
RIL
54
Rothschild Investment LLC
Illinois
$42K – – –
Man Group
55
Man Group
United Kingdom
$42K +$39.7K +12,016 New
LP
56
LMR Partners
United Kingdom
$36K – – –
CBT
57
Central Bank & Trust
Kentucky
$27K – – –
TRCT
58
Tower Research Capital (TRC)
New York
$26K -$1.69K -512 -6%
Royal Bank of Canada
59
Royal Bank of Canada
Ontario, Canada
$20K +$10K +3,028 +114%
PFBT
60
Parkside Financial Bank & Trust
Missouri
$11K +$3.97K +1,200 +60%
Group One Trading
61
Group One Trading
Illinois
$11K +$9.88K +2,986 New
Citigroup
62
Citigroup
New York
$10K +$4.78K +1,444 +103%
Rockefeller Capital Management
63
Rockefeller Capital Management
New York
$4K – – –
CUAMC
64
China Universal Asset Management Company
China
$3K +$2.66K +804 New
Bank of Montreal
65
Bank of Montreal
Ontario, Canada
$2.1K +$1.71M +517,900 New
BNP Paribas Financial Markets
66
BNP Paribas Financial Markets
France
$1.6K +$1.5K +452 New
Jacobs Levy Equity Management
67
Jacobs Levy Equity Management
New Jersey
– -$233K -90,445 Closed
State of Wisconsin Investment Board
68
State of Wisconsin Investment Board
Wisconsin
– -$63K -24,322 Closed
State of Tennessee, Department of Treasury
69
State of Tennessee, Department of Treasury
Tennessee
– -$48K -18,705 Closed
DU
70
Delphia (USA)
Ontario, Canada
– -$41K -15,799 Closed
CC
71
Corton Capital
Ontario, Canada
– -$39K -14,978 Closed
Acadian Asset Management
72
Acadian Asset Management
Massachusetts
– -$31K -12,099 Closed
Russell Investments Group
73
Russell Investments Group
United Kingdom
– -$21K -8,421 Closed
TWC
74
TD Waterhouse Canada
Ontario, Canada
– -$3.75K -1,500 Closed
New York State Common Retirement Fund
75
New York State Common Retirement Fund
New York
– -$1K -307 Closed
1 2
3
4

PSTX Hedge Fund Activity: Q3 2022 in Review

68 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Poseida Therapeutics, Inc. Common Stock (PSTX) for Q3 2022, worth a combined $140M — up 141% from $58.1M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new PSTX positions and 12 closed out — a net gain of 12 holders — while 20 added to existing stakes and 11 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $10.4M. The largest seller was Millennium Management, cutting an estimated $2.85M.

  • 68 institutional investors held Poseida Therapeutics, Inc. Common Stock (PSTX) as of Q3 2022, up from 56 in Q2 2022.
  • Funds reported $140M of Poseida Therapeutics, Inc. Common Stock stock for Q3 2022, up 141% quarter-over-quarter.
  • 24 funds opened new Poseida Therapeutics, Inc. Common Stock positions in Q3 2022 and 12 closed out, a net change of +12 holders.
  • The largest Poseida Therapeutics, Inc. Common Stock buyer in Q3 2022 was Fidelity Investments, an estimated $10.4M added.
  • The largest Poseida Therapeutics, Inc. Common Stock seller in Q3 2022 was Millennium Management, an estimated $2.85M sold.

Based on aggregated 13F filings for Q3 2022.